Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 5
2009 2
2010 5
2011 2
2012 1
2014 2
2015 5
2016 2
2017 4
2018 1
2019 4
2020 1
2021 3
2022 7
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study.
Ben Khaled N, Mörtl B, Beier D, Reiter FP, Pawlowska-Phelan D, Teufel A, Rössler D, Schwade DF, Philipp A, Kubisch I, Ehmer U, Geier A, Lange CM, Mayerle J, Berger K, De Toni EN, Munker S. Ben Khaled N, et al. Among authors: ehmer u. Eur J Cancer. 2024 Feb;198:113499. doi: 10.1016/j.ejca.2023.113499. Epub 2023 Dec 15. Eur J Cancer. 2024. PMID: 38160177 No abstract available.
Human hepatic organoids for the analysis of human genetic diseases.
Guan Y, Xu D, Garfin PM, Ehmer U, Hurwitz M, Enns G, Michie S, Wu M, Zheng M, Nishimura T, Sage J, Peltz G. Guan Y, et al. Among authors: ehmer u. JCI Insight. 2023 Oct 23;8(20):e176034. doi: 10.1172/jci.insight.176034. JCI Insight. 2023. PMID: 37870959 Free PMC article. No abstract available.
Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates.
Payani E, Koliogiannis D, Schoenberg MB, Koch D, Eser-Valeri D, Denk G, Rehm M, Schäfer S, Ehmer U, Kremer AE, Meiser B, Werner J, Guba M, Börner N. Payani E, et al. Among authors: ehmer u. J Clin Med. 2023 Sep 10;12(18):5880. doi: 10.3390/jcm12185880. J Clin Med. 2023. PMID: 37762820 Free PMC article.
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study.
Ben Khaled N, Mörtl B, Beier D, Reiter FP, Pawlowska-Phelan D, Teufel A, Rössler D, Schwade DF, Philipp A, Kubisch I, Ehmer U, Geier A, Lange CM, Mayerle J, Berger-Thürmel K, De Toni EN, Munker S. Ben Khaled N, et al. Among authors: ehmer u. Eur J Cancer. 2023 Oct;192:113248. doi: 10.1016/j.ejca.2023.113248. Epub 2023 Jul 21. Eur J Cancer. 2023. PMID: 37672814
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study.
Welland S, Leyh C, Finkelmeier F, Jefremow A, Shmanko K, Gonzalez-Carmona MA, Kandulski A, Jeliazkova P, Best J, Fründt TW, Djanani A, Pangerl M, Maieron A, Greil R, Fricke C, Sookthai D, Günther R, Schmiderer A, Wege H, Venerito M, Ehmer U, Müller M, Strassburg CP, Weinmann A, Siebler J, Waidmann O, Lange CM, Saborowski A, Vogel A. Welland S, et al. Among authors: ehmer u. Liver Cancer. 2022 Jan 14;11(3):219-232. doi: 10.1159/000521746. eCollection 2022 Jun. Liver Cancer. 2022. PMID: 35949288 Free PMC article.
46 results